Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chabannon

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Bone Marrow Transplantation|November 3, 2015
Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicityS Garciaz, D Coso, J-M Schiano de Collela, et al.
Bone Marrow Transplantation|September 1, 1996
A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignanciesN Vey, B De Prijck, C Faucher, et al.
Anticancer Research|August 6, 2000
Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: a phase I-II studyD Genre, P Viens, G Gravis, et al.
Bone Marrow Transplantation|June 27, 2012
Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphomaR Crocchiolo, L Castagna, S Fürst, et al.
Bone Marrow Transplantation|January 23, 1999
Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot studyD Blaise, E Jourdan, M Michallet, et al.
Bone Marrow Transplantation|October 17, 2003
Massive ascites of donor T-cell origin in a patient with acute GVHD after a reduced-intensity allograft for CLLV Ivanov, C Faucher, K Bilger, et al.
Bone Marrow Transplantation|September 1, 2000
High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantationM Mohty, C Faucher, N Vey, et al.
European Cytokine Network|June 5, 1998
Benefits of granulocyte-colony-stimulating factor after stem cell transfusion in intensive sequential chemotherapy for breast cancerP Viens, D Genre, C Protière, et al.
Leukemia & Lymphoma|August 28, 1998
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institutionS Oddou, N Vey, P Viens, et al.
Bone Marrow Transplantation|June 25, 2002
Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimensD Genre, P Viens, F Bertucci, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Bone Marrow Transplantation|November 3, 2015
Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicityS Garciaz, D Coso, J-M Schiano de Collela, et al.
Bone Marrow Transplantation|September 1, 1996
A pilot study of busulfan and melphalan as preparatory regimen prior to allogeneic bone marrow transplantation in refractory or relapsed hematological malignanciesN Vey, B De Prijck, C Faucher, et al.
Anticancer Research|August 6, 2000
Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: a phase I-II studyD Genre, P Viens, G Gravis, et al.
Bone Marrow Transplantation|June 27, 2012
Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphomaR Crocchiolo, L Castagna, S Fürst, et al.
Bone Marrow Transplantation|January 23, 1999
Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot studyD Blaise, E Jourdan, M Michallet, et al.
Bone Marrow Transplantation|October 17, 2003
Massive ascites of donor T-cell origin in a patient with acute GVHD after a reduced-intensity allograft for CLLV Ivanov, C Faucher, K Bilger, et al.
Bone Marrow Transplantation|September 1, 2000
High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantationM Mohty, C Faucher, N Vey, et al.
European Cytokine Network|June 5, 1998
Benefits of granulocyte-colony-stimulating factor after stem cell transfusion in intensive sequential chemotherapy for breast cancerP Viens, D Genre, C Protière, et al.
Leukemia & Lymphoma|August 28, 1998
Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institutionS Oddou, N Vey, P Viens, et al.
Bone Marrow Transplantation|June 25, 2002
Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimensD Genre, P Viens, F Bertucci, et al.
Pageof 14